[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335692-105":59,"doc-detail-335692-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","genomic-and-transcriptomic-profiling-of-radioresistant-prostate-and-head-and-neck-cancers-implicate-a-bahd1-dependent-modification-of-dna-damage-at-the-heterochromatin-research-and-findings-summary","Genomic and transcriptomic profiling of radioresistant prostate and head and neck cancers implicate a BAHD1-dependent modification of DNA damage at the heterochromatin - Research and findings summary","","Radiotherapy is widely used for cancer treatment, yet acquired radioresistance remains a clinical obstacle driven by multiple intrinsic and tumor microenvironment factors. Using four prostate (22Rv1, DU145) and head and neck (FaDu, HK1) models irradiated to 90 Gy, researchers compared whole-exome and transcriptome profiles between radioresistant and wild-type cells. The work identified enriched mismatch repair mutational signatures, dysregulated genes, and a BAHD1-associated increase in heterochromatin marks H3K9me3 and H3K27me3. BAHD1 knockdown reversed radioresistance and reduced DNA double-strand break repair, while cohort analyses linked higher heterochromatin activity with increased treatment failure risk.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genomic-and-transcriptomic-profiling-of-radioresistant-prostate-and-head-and-neck-cancers-implicate-a-bahd1-dependent-modification-of-dna-damage-at-the-heterochromatin-research-and-findings-summary/335692/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genomic-and-transcriptomic-profiling-of-radioresistant-prostate-and-head-and-neck-cancers-implicate-a-bahd1-dependent-modification-of-dna-damage-at-the-heterochromatin-research-and-findings-summary/335692.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"How were the radioresistant cancer models generated for this study?","Question",{"text":112,"@type":113},"Researchers irradiated the parental wild-type prostate and head and neck cancer cell lines with 90 Gy, simulating fractionated radiotherapy delivery with longer breaks between weekly courses to obtain radioresistant models.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What genomic and transcriptomic signals were found in radioresistant cells?",{"text":117,"@type":113},"Comparative analyses showed enrichment of mismatch repair mutational signatures across cell lines and identified non-synonymous variants affecting pro-survival pathways. Despite transcriptomic heterogeneity, 18 dysregulated genes were shared across the four models, including increased BAHD1 expression.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does BAHD1 play in radioresistance and heterochromatin formation?",{"text":121,"@type":113},"BAHD1-dependent heterochromatin formation was supported by increased H3K9me3 and H3K27me3 expression after irradiation. siRNA knockdown of BAHD1 preferentially reduced these marks in radioresistant cells and reversed radioresistance in clonogenic assays.",{"name":123,"@type":110,"acceptedAnswer":124},"How are the findings connected to DNA damage repair and clinical outcomes?",{"text":125,"@type":113},"Inhibiting the BAHD1-heterochromatin formation axis reduced DNA double-strand break repair. Analyses of prostate and head and neck radiotherapy cohorts suggested higher failure risk in tumors with high heterochromatin activity.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},335692,1790810744,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":4},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nGenomic and transcriptomic proﬁling of radioresistant prostate and head and neck cancers implicate a BAHD1-dependent modiﬁcation of DNA damage at the heterochromatin  \nChaw Yee Beh 1,5, Celestia Pei Xuan Yeo1,5, Boon Hao Hong 1,5, Evelyn Mui Cheng Tan1, Kah Min Tan1, Dennis Jun Jie Poon 1, Pek Lim Chu1, Dewi Susanti 1, Pei Ling Tai1, Monica Ryu2, James Proudfoot2, Eugenia Li Ling Yeo 1, Khee Chee Soo 1 and Melvin L. K. Chua 1,3,4 ✉  \n© The Author(s) 2024  \n\n|  | Radiotherapy is an integral modality in treating human cancers, but radioresistance remains a clinical challenge due to the involvement of multiple intrinsic cellular and extrinsic tumour microenvironment factors that govern radiosensitivity. To study the intrinsic factors that are associated with cancer radioresistance, we established 4 radioresistant prostate (22Rv1 and DU145) and head and neck cancer (FaDu and HK1) models by irradiating their wild-type parentals to 90 Gy, mimicking the fractionated radiotherapy schema that is often using in the clinic, and performed whole exome and transcriptome sequencing of the radioresistant and wild-type models. Comparative genomic analyses detected the enrichment of mismatch repair mutational signatures (SBS6, 14, 15, 20) across all the cell lines and several non-synonymous single nucleotide variants involved in pro-survival pathways. Despite signiﬁcant inter-cell type heterogeneity of their transcriptomic proﬁles, 18 common dysregulated genes (5 upregulated and 13 downregulated) were identiﬁed across the 4 models, including the overexpression of bromo-adjacent homology domain containing 1 (BAHD1) gene, which is involved in heterochromatin formation. Interestingly, this coincided with our observation of increased histone 3 lysine 9 trimethylation (H3K9me3) and histone 3 lysine 27 trimethylation (H3K27me3) expression post-irradiation in our radioresistant cells. The dependency between BAHD1 and heterochromatin formation was conﬁrmed by siRNA knockdown of BAHD1, indicating preferential reduction of H3K9me3 and H3K27me3 expression in the radioresistant cells, but not the wild-type parentals, and conﬁrmed by clonogenic assays showing reversal of radioresistance postsiBAHD1 treatment. We further showed that inhibition of the BAHD1-heterochromatin formation axis led to reduced DNA doublestrand break repair. Finally, analyses of treatment outcomes in 4 prostate and head and neck cancer radiotherapy cohorts suggested an increased risk of failures in tumours of high heterochromatin activity. Taken together, our results support a new model implicating BAHD1-dependent modulation of the heterochromatin in acquired radioresistance of prostate and head and |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| neck cancers. |  |  |\n|  | Cell Death and Disease (2024)15:929; [https://doi.org/10.1038/s41419-024-07316-y](https://doi.org/10.1038/s41419-024-07316-y) |  |\n|  |  |  |\n\nINTRODUCTION  \nRadiotherapy (RT) is an integral modality in the treatment of human cancers, with over 50% of cancer patients requiring RT during their treatment journey [1] . In the clinic, RT can be deployed in combination with surgery, or as a deﬁnitive treatment for organ preservation [2–4] . The conventional dogma of how RT exerts its anti-cancer effects is through either direct DNA damage from ionisation radiation or indirectly through production of reactive oxygen species [5] . However, current evidence suggests that radiosensitivity of cancers is dependent on several pathways including apoptosis, necrosis, autophagy, senescence, and more recently, immunogenic cell death mechanisms like necroptosisand ferroptosis [6–9] .  \nFactors like the oxygenation status of the tumour microenvironment (TME) also inﬂuence the efﬁcacy of RT on the c","cbCaisVX4G1dEVpA","https://ap.wps.com/l/cbCaisVX4G1dEVpA","pdf",3661895,13,"English","# Introduction\n## Radiotherapy and mechanisms of radiosensitivity\n## Intrinsic versus acquired radioresistance\n# Study design and genomic/transcriptomic profiling\n## Establishment of radioresistant prostate and head & neck models\n## Whole-exome and transcriptome sequencing\n# Key findings on heterochromatin and BAHD1\n## Dysregulated gene programs across models\n## H3K9me3/H3K27me3 changes after irradiation\n## BAHD1 dependency and functional validation\n# DNA repair implications and clinical associations\n## Effects of BAHD1-heterochromatin axis inhibition\n## Treatment-outcome analyses in patient cohorts","[{\"question\":\"How were the radioresistant cancer models generated for this study?\",\"answer\":\"Researchers irradiated the parental wild-type prostate and head and neck cancer cell lines with 90 Gy, simulating fractionated radiotherapy delivery with longer breaks between weekly courses to obtain radioresistant models.\"},{\"question\":\"What genomic and transcriptomic signals were found in radioresistant cells?\",\"answer\":\"Comparative analyses showed enrichment of mismatch repair mutational signatures across cell lines and identified non-synonymous variants affecting pro-survival pathways. Despite transcriptomic heterogeneity, 18 dysregulated genes were shared across the four models, including increased BAHD1 expression.\"},{\"question\":\"What role does BAHD1 play in radioresistance and heterochromatin formation?\",\"answer\":\"BAHD1-dependent heterochromatin formation was supported by increased H3K9me3 and H3K27me3 expression after irradiation. siRNA knockdown of BAHD1 preferentially reduced these marks in radioresistant cells and reversed radioresistance in clonogenic assays.\"},{\"question\":\"How are the findings connected to DNA damage repair and clinical outcomes?\",\"answer\":\"Inhibiting the BAHD1-heterochromatin formation axis reduced DNA double-strand break repair. Analyses of prostate and head and neck radiotherapy cohorts suggested higher failure risk in tumors with high heterochromatin activity.\"}]","Genomic and transcriptomic profiling of radioresistant prostate and head and neck cancers implicate a BAHD1-dependent modification of DNA damage at the heterochromatin - Research and findings summary | PDF",1790011958,33]